Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 7, 2026; 32(13): 115810
Published online Apr 7, 2026. doi: 10.3748/wjg.v32.i13.115810
Published online Apr 7, 2026. doi: 10.3748/wjg.v32.i13.115810
Table 3 Patient-specific clinical diagnoses and impact on medical management
| ID | Clinical diagnosis | Clinical implication |
| 6 | Wiskott-Aldrich syndrome or related phenotypes | Nil |
| 14 | X-linked chronic granulomatous disease | Requires BMT; no response to conventional therapy |
| 15 | X-linked chronic granulomatous disease | Requires BMT; no response to conventional therapy |
| 16 | Combined immunodeficiency with multiple intestinal atresias | Initiated leflunomide, counseled on immunodeficiency risk |
| 17 | Mitochondrial DNA depletion syndrome | Liver transplant referral; neurology referral; prenatal screening recommended |
| 19 | Trisomy 18 | Liver transplant not pursued |
| 20 | Crigler-Najjar (and Gilbert syndrome) | Intensive phototherapy; phenobarbital; transplant counseling; potential gene therapy |
| 21 | Gilbert syndrome | Avoidance of further testing |
| 23 | PFIC 1 | UDCA, IBAT inhibitor; hearing test; anticipate cirrhosis and possible liver transplant |
| 24 | Crigler-Najjar | Intensive phototherapy; phenobarbital; transplant counseling; potential gene therapy |
| 25 | Alagille syndrome | Screening for associated disorders: Cardiac, ocular, vascular, and renal |
| 26 | Alagille syndrome | Screening for associated disorders: Cardiac, ocular, vascular, and renal |
| 27 | PFIC 3 | UDCA, IBAT inhibitor; slower disease progression |
| 28 | PFIC 3/autosomal recessive nonsyndromic hearing loss/glucose-6-phosphate dehydrogenase deficiency | UDCA, IBAT inhibitor; slower disease progression; counseling on post–liver transplant recurrence; G6PD precautions; hearing test; ENT referral |
| 34 | Congenital bile acid synthesis defect | Bile acid replacement therapy; liver transplant considered |
| 35 | Gilbert syndrome | Avoidance of further testing |
| 37 | Gilbert syndrome | Avoidance of further testing |
| 38 | Gilbert syndrome | Avoidance of further testing |
| 40 | Alagille syndrome | IBAT inhibitor, screening for associated disorders: Cardiac, ocular, vascular, and renal |
| 43 | Hereditary pancreatitis | Annual pancreatic cancer screening; regular monitoring of exocrine/endocrine function |
| 44 | Chronic pancreatitis | Regular monitoring of exocrine/endocrine function |
| 45 | TE, hyperphenylalaninemia, familial cold autoinflammatory syndrome | Family counseling for future pregnancies; MVT not favored as symptoms may improve |
| 48 | MVID | Family counseling for future pregnancies; renal screening; MVT likely as symptoms unlikely to improve; lifelong TPN anticipated |
| 49 | TE | Family counseling for future pregnancies; MVT not favored as symptoms may improve |
| 50 | MVID | Family counseling for future pregnancies; renal screening; MVT likely as symptoms unlikely to improve; lifelong TPN anticipated |
| 51 | Trichohepatoenteric syndrome | Screening for hypogammaglobulinemia, screening for liver disease |
| 52 | MVID | Family counseling for future pregnancies; renal screening; MVT likely as symptoms unlikely to improve; lifelong TPN anticipated |
| 53 | Trichohepatoneurodevelopmental syndrome | Screening for developmental delay, screening for liver disease |
| 56 | Congenital chloride diarrhea | Chloride supplementation |
| 57 | Recurrent respiratory infections and failure to thrive with or without diarrhea | Family counseling for future pregnancies |
| 58 | MVID | Family counseling for future pregnancies; renal screening; MVT likely as symptoms unlikely to improve; lifelong TPN anticipated |
| 59 | Congenital diarrheal disorder due to DGAT1 deficiency | Family counseling for future pregnancies; considering MVT |
| 61 | Cystic fibrosis | Annual screening for pancreatic insufficiency, started Trikafta |
| 63 | Autosomal recessive TRK 1 positive congenital insensitivity to pain with anhydrosis | Antipyretics and cooling measures; trauma precautions due to absent pain; screen for immunoglobulin deficiency |
| 64 | Immunodeficiency | Screening for immunodeficiency |
| 65 | BRAF gene related disorders (cardiofaciocutaneous syndrome, Noonan syndrome and LEOPARD syndrome) | Family counseling regarding high risk of developing tumors, referral to cardiology, started Growth hormone |
| 68 | Peutz-Jeghers syndrome | Regular endoscopic screening; genetic testing for first-degree relatives |
| 69 | Peutz-Jeghers syndrome | Regular endoscopic screening; genetic testing for first-degree relatives |
- Citation: Alsarhan A, Alloush R, Jain R, Abou Tayoun A, Tzivinikos C. Clinical utility of genomic investigations in a Middle Eastern pediatric gastroenterology disease cohort. World J Gastroenterol 2026; 32(13): 115810
- URL: https://www.wjgnet.com/1007-9327/full/v32/i13/115810.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i13.115810